BREAKTHROUGH CAR-T THERAPY IN REFRACTORY B-CELL LYMPHOMA: MIOT INTERNATIONAL CHENNAI, INDIA CASE STUDY. hncmc [Internet]. 2025 May 3 [cited 2026 Aug. 16];:143-4. Available from: https://www.hnchmc.uz/jour/article/view/182